Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas S Reger

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of 4,4-Disubstituted Quinazolin-2-ones as T-Type Calcium Channel AntagonistsJames C Barrow, Kenneth E Rittle, Thomas S Reger, et al.
Cell Biochemistry and Biophysics|July 8, 2009
Positive allosteric interaction of structurally diverse T-type calcium channel antagonistsVictor N Uebele, Cindy E Nuss, Steven V Fox, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 2014
Discovery of MK-3697: a selective orexin 2 receptor antagonist (2-SORA) for the treatment of insomniaAnthony J Roecker, Thomas S Reger, M Christa Mattern, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Short-acting T-type calcium channel antagonists significantly modify sleep architecture in rodentsZhi-Qiang Yang, Kelly-Ann S Schlegel, Youheng Shu, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of 4,4-Disubstituted Quinazolin-2-ones as T-Type Calcium Channel AntagonistsJames C Barrow, Kenneth E Rittle, Thomas S Reger, et al.
Cell Biochemistry and Biophysics|July 8, 2009
Positive allosteric interaction of structurally diverse T-type calcium channel antagonistsVictor N Uebele, Cindy E Nuss, Steven V Fox, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 2014
Discovery of MK-3697: a selective orexin 2 receptor antagonist (2-SORA) for the treatment of insomniaAnthony J Roecker, Thomas S Reger, M Christa Mattern, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Short-acting T-type calcium channel antagonists significantly modify sleep architecture in rodentsZhi-Qiang Yang, Kelly-Ann S Schlegel, Youheng Shu, et al.
Pageof 2